MYO1G and hepatocellular carcinoma: Our research is aimed at identifying and validating effective noninvasive biomarkers for HCC management, and our previously published study has indicated that hypermethylation of SCAND3 and Myo1g gene was a potential diagnostic biomarker for hepatocellular carcinoma [17].